Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-6 secretion is the process by which cells, predominantly immune cells like macrophages and T cells, release the cytokine interleukin-6 in response to stimuli such as infection, injury, or inflammation. IL-6 acts via classic or trans-signaling through its receptor complex, leading to diverse effects on immune modulation, inflammation, and acute phase responses. Dysregulation of IL-6 secretion is implicated in a wide range of pathological conditions, especially chronic inflammatory diseases and cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-6 secretion.